Investor Relations
Investors
February 7, 2018

Sanofi Q4 and Full Year 2017 Results

At a glance

Q4 and FY 2017 Video

Sanofi – Annual Results 2017 - Video Interview with Olivier Brandicourt, CEO

Bill Sibold
BROKER CONFERENCES

Leerink Partners Healthcare Conference - Bill Sibold

February 15, 2018

Upcoming events

12
Mar 2018
Cowen Healthcare Conference
7:30 pm CET: Audiocast of the presentation
27
Avr 2018
First quarter results 2018
Conference call
IR call on the acquisition of Bioverativ
INVESTOR PRESENTATIONS

IR call on the acquisition of Bioverativ

January 22, 2018
IR call on the acquisition of Bioverativ
INVESTOR PRESENTATIONS

IR call on the acquisition of Ablynx

January 29, 2018

Contact the Investor Relations team

54 rue La Boétie
75008 Paris FRANCE

France +33 (0)1 53 77 45 45 • ir@sanofi.com

United States +1 908 981 5560

Press releases

Press releases

In-depth reading

Sustaining Innovation Analyst Day
Décember 13, 2017

Sustaining Innovation Analyst Day

Sanofi hosted an analyst meeting to discuss Sanofi’s R&D strategy and development pipeline on December 13, 2017 in Paris.
Olivier Brandicourt
Broker conferences

JP Morgan Healthcare Conference - Olivier Brandicourt

January 9, 2018
Annual General Meetings

Annual General Meetings

2017 Dividend

2017 Dividend

Board proposes dividend of €3.03, an increase of 2.4%
Annual Report on Form 20-F 2016

Annual Report on Form 20-F 2016

Individual shareholders

Direct access to Individual shareholders - Welcome to Sanofi

Access your dedicated section

Shareholder Handbook 2017

Shareholder Handbook 2017

Integrated Report 2016

Letter to shareholders – January 2018

Sanofi IR app on different devices

SANOFI IR
The Investor Relations app

SANOFI IR provides financial information with direct access to key news, events, publications and a dedicated section for individual shareholders
Download the IR app on the App Store Get the IR app on Google Play